RUNX1 and acute myeloid leukemia: There were limited numbers of patients in our single-center retrospective study, it wasn’t found that normal or elevated platelet counts were frequently detected in AML patents with some genetic mutations or cytogenetic abnormalities as RUNX1 and chromosome 3q abnormalities, which were reported in other studies [59, 60].